Planar and SPECT imaging in the era of PET and PET-CT: Can it survive the test of time?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 8, 2008, Pages 1554-1559

  Alavi, Abass ^a   Basu, Sandip ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; INDIUM 111; IODINE 123; IODINE 124; IODINE 131; METHIONINE C 11; PERTECHNETIC ACID TC 99M; RADIOPHARMACEUTICAL AGENT; YTTRIUM 86; YTTRIUM 90;

COMPUTER ASSISTED TOMOGRAPHY; CYCLOTRON; GAMMA RADIATION; IMAGE QUALITY; MOTOR DYSFUNCTION; POSITRON EMISSION TOMOGRAPHY; PSYCHOPATHY; QUALITY CONTROL; REVIEW; SEIZURE; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER;

FORECASTING; IMAGE ENHANCEMENT; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48149100934     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0813-2     Document Type: Review

References (96)

1. HM Bigott R Laforest X Liu A Ruangma F Wuest MJ Welch 2006 Advances in the production, processing and microPET image quality of technetium-94m Nucl Med Biol 33 7 923 933
2. 94mTc for PET imaging Appl Radiat Isotopes 46 2 69 73(5)
3. CK Stone BT Christian RJ Nickles SB Perlman 1994 Technetium 94m-labeled methoxyisobutyl isonitrile: dosimetry and resting cardiac imaging with positron emission tomography J Nucl Cardiol 1 5 Pt 1 425 433
4. RJ Nickles AD Nunn CK Stone BT Christian 1993 Technetium-94m-teboroxime: synthesis, dosimetry and initial PET imaging studies J Nucl Med 34 7 1058 1066
5. H Schirrmeister A Guhlmann K Elsner J Kotzerke G Glatting M Rentschler 1999 Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET J Nucl Med 40 10 1623 1629
6. RM Lambrecht N Woodhouse R Phillips D Wolczak A Qureshi ED Reyes 1988 Investigational study of iodine-124 with a positron camera Am J Physiol Imaging 3 4 197 200
7. KS Pentlow MC Graham RM Lambrecht F Daghighian SL Bacharach B Bendriem 1996 Quantitative imaging of iodine-124 with PET J Nucl Med 37 9 1557 1562
8. 124I Eur J Nucl Med 10 9-10 472 476
9. DC Crawford MA Flower BE Pratt C Hill J Zweit VR McCready 1997 Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography Eur J Nucl Med 24 12 1470 1478
10. SM Eschmann G Reischl K Bilger J Kupferschlager MH Thelen BM Dohmen 2002 Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET Eur J Nucl Med Mol Imaging 29 6 760 767
11. RJ Ott V Batty BS Webb MA Flower MO Leach R Clack 1987 Measurement of radiation dose to the thyroid using positron emission tomography Br J Radiol 60 711 245 251
12. YE Erdi H Macapinlac SM Larson AK Erdi H Yeung EE Furhang 1999 Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging Clin Positron Imaging 2 1 41 46
13. LS Freudenberg G Antoch W Jentzen R Pink J Knust R Gorges 2004 Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer Eur Radiol 14 11 2092 2098
14. 124I PET and 3-dimensional-internal dosimetry (3D-ID) software J Nucl Med 45 8 1366 1372
15. SM Larson R Robbins 2002 Positron emission tomography in thyroid cancer management Semin Roentgenol. 37 2 169 174
16. MA Bakir S Eccles JW Babich N Aftab J Styles CJ Dean 1992 c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies J Nucl Med 33 12 2154 2160
17. SM Larson KS Pentlow ND Volkow AP Wolf RD Finn RM Lambrecht 1992 PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma J Nucl Med 33 11 2020 2023
18. F Daghighian KS Pentlow SM Larson MC Graham GR DiResta SD Yeh 1993 Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma Eur J Nucl Med 20 5 402 409
19. JG Tjuvajev M Doubrovin T Akhurst S Cai J Balatoni MM Alauddin 2002 Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression J Nucl Med 43 8 1072 1083
20. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice J Nucl Med 44 12 1962 1969
21. MK Robinson M Doss C Shaller D Narayanan JD Marks LP Adler 2005 Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody Cancer Res 65 4 1471 1478
22. 124I-annexin V and PET Nucl Med Biol 32 4 395 402
23. KJ Kairemo 1993 Positron emission tomography of monoclonal antibodies Acta Oncol 32 7-8 825 830
24. 124I]Iodo-2¢- deoxyuridine for functional PET imaging of cell proliferation Nucl Med Biol 25 4 359 365
25. 11C hydroxyephedrine PET Radiology 230 2 423 428
26. 18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma Ann Surg Oncol 13 2 187 197
27. 123I-MIBG SPECT/CT J Nucl Med 47 10 1635 1642
28. 18F DOPA whole body PET-initial results Radiology 222 507 512
29. 18F] fluorodopamine positron emission tomography (PET) scanning for diagnostic localization of pheochromocytoma Hypertension 38 6 8
30. S Hoegerle C Altehoefer N Ghanem G Koehler CF Waller H Scheruebl 2001 Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors Radiology 220 2 373 380
31. M Pietila K Malminiemi H Ukkonen M Saraste K Nagren P Lehikoinen 2001 Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure Eur J Nucl Med 28 3 373 376
32. 123I-MIBG uptake Eur J Nucl Med Mol Imaging 33 8 871 878
33. 11C-meta-hydroxyephedrine retention on norepinephrine transporter density J Nucl Med 47 9 1490 1496
34. 124I-mIBG positron emission tomography Br J Radiol 65 777 787 791
35. B Shapiro 1995 Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks Q J Nucl Med. 39 4 Suppl 1 150 155
36. 90Y-DOTATOC therapy Eur J Nucl Med Mol Imaging 33 4 460 466
37. PM Smith-Jones B Stolz C Bruns R Albert HW Reist R Fridrich 1994 Gallium-67/gallium-68-[DFO]-octreotide-a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies J Nucl Med 35 2 317 325
38. 68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors Horm Metab Res 26 10 453 459
39. 68GA] DOTA-d-Phe1-Tyr3-octreotide: first results in patients with meningiomas J Nucl Med 42 7 1053 1056
40. 111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors Mol Imaging Biol 5 1 42 48
41. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy J Urol 176 3 954 960
42. 11C-choline PET and MR imaging combined with proton MR spectroscopy Eur J Nucl Med Mol Imaging 32 7 742 748
43. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging Urol Int 74 3 214 220
44. 11C]choline does not correlate with cell proliferation in human prostate cancer Eur J Nucl Med Mol Imaging 32 6 668 673
45. 11C-choline the most appropriate tracer for prostate cancer? For Eur J Nucl Med Mol Imaging 31 5 753 756
46. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer Eur Urol 44 1 32 38
47. 18F]fluorodeoxyglucose-positron emission tomography J Urol 169 4 1337 1340
48. H Schoder SM Larson 2004 Positron emission tomography for prostate, bladder, and renal cancer Semin Nucl Med 34 4 274 292
49. 11C-acetate positron emission tomography for occult prostate cancer Urol Oncol 24 5 410 411
50. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer J Clin Oncol 24 16 2513 2519
51. 11C-acetate and 18F-FDG in prostate cancer patients Eur J Nucl Med Mol Imaging 30 4 607 611
52. J Kotzerke BG Volkmer B Neumaier JE Gschwend RE Hautmann SN Reske 2002 Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer Eur J Nucl Med Mol Imaging 29 10 1380 1384
53. 11C-acetate PET imaging of prostate cancer J Nucl Med 43 2 181 186
54. H Herzog F Rosch G Stocklin C Lueders SM Qaim LE Feinendegen 1993 Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics J Nucl Med 34 12 2222 2226
55. 90Y-labelled analogue Eur J Nucl Med 26 4 358 366
56. 111In-pentetreotide in patients with advanced neuroendocrine tumours Eur J Nucl Med Mol Imaging 31 10 1386 1392
57. T Kull J Ruckgaber R Weller S Reske G Glatting 2004 Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D mode Cancer Biother Radiopharm 19 4 482 490
58. 111In labeled Herceptin Nucl Med Biol 29 5 599 606
59. R Parry D Schneider D Hudson D Parkes JA Xuan A Newton 2005 Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer Cancer Res 65 18 8397 8405
60. HS Chong DE Milenic K Garmestani ED Brady H Arora C Pfiester 2006 In vitro and in vivo evaluation of novel ligands for radioimmunotherapy Nucl Med Biol 33 4 459 467
61. H Lundqvist M Lubberink V Tolmachev A Lovqvist A Sundin S Beshara 1999 Positron emission tomography and radioimmunotargeting-general aspects Acta Oncol 38 3 335 341
62. 18F-FDG PET in detecting infected lower limb prosthesis implants J Nucl Med 42 44 48
63. H Zhuang PS Duarte A Rebenstock Q Feng A Alavi 2003 Pulmonary Clostridium perfringens infection detected by FDG positron emission tomography Clin Nucl Med 28 517 518
64. 18F-FDG PET imaging for differentiating malignant from inflammatory processes J Nucl Med 42 1412 1417
65. TK Chacko H Zhuang K Stevenson B Moussavian A Alavi 2002 The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses Nucl Med Commun 23 851 855
66. S Basu T Chryssikos M Houseni D Scot Malay J Shah HM Zhuang A Alavi 2007 Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun 28 465 472
67. 18F-labeled fluorodeoxyglucose PET in the management of patients with arthroplasty Radiol Clin North Am 45 4 711 718
68. J Meller CO Sahlmann T Liersch P Hao Tang A Alavi 2007 Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-d-glucose PET in the detection of osteomyelitis Radiol Clin North Am 45 4 719 733
69. R Kumar S Basu D Torigian V Anand H Zhuang A Alavi 2008 Role of modern imaging techniques for diagnosis of infection in the era of 18F- fluorodeoxyglucose positron emission tomography Clin Microbiol Rev 21 1 209 224
70. H Zhuang JQ Yu A Alavi 2005 Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders Radiol Clin North Am 43 121 134
71. S Basu H Zhuang A Alavi 2007 Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates Clin Nucl Med 32 7 567 568
72. S Basu S Alzeair G Li S Dadparvar A Alavi 2007 Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro-d-glucose-positron emission tomography: significance of an incidental finding and in the setting of a known pulmonary disease Mol Imaging Biol 9 6 333 339
73. H Zhuang A Alavi 2002 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation Semin Nucl Med 32 1 47 59
74. DJ Burn GV Sawle DJ Brooks 1994 Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-DOPA PET data J Neurol Neurosurg Psychiatry 57 278 284
75. R Hustinx M Pourdehnad B Kaschten A Alavi 2005 PET imaging for differentiating recurrent brain tumor from radiation necrosis Radiol Clin North Am 43 1 35 47
76. A Alavi JB Alavi RE Lenkinski 1990 Complementary roles of PET and MR spectroscopy in the management of brain tumors Radiology 177 3 617 618
77. JB Alavi A Alavi J Chawluk M Kushner J Powe W Hickey 1988 Positron emission tomography in patients with glioma. A predictor of prognosis Cancer 62 6 1074 1078
78. R Hustinx RJ Smith F Benard A Bhatnagar A Alavi 1999 Can the standardized uptake value characterize primary brain tumors on FDG-PET? Eur J Nucl Med 26 11 1501 1509
79. G Di Chiro RA Brooks NJ Patronas D Bairamian PL Kornblith BH Smith 1984 Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors Ann Neurol 15 Suppl S138 S146
80. G Di Chiro J Hatazawa DA Katz HV Rizzoli DJ De Michele 1987 Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study Radiology 164 2 521 526
81. G Di Chiro E Oldfield DC Wright D De Michele DA Katz NJ Patronas 1988 Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies AJR Am J Roentgenol 150 1 189 197
82. G Di Chiro RA Brooks 1988 PET-FDG of untreated and treated cerebral gliomas J Nucl Med 29 3 421 423
83. PR Jolles PR Chapman A Alavi 1989 PET, CT, and MRI in the evaluation of neuropsychiatric disorders: current applications J Nucl Med 30 10 1589 1606
84. JB Chawluk A Alavi R Dann HI Hurtig S Bais MJ Kushner 1987 Positron emission tomography in aging and dementia: effect of cerebral atrophy J Nucl Med 28 4 431 437
85. Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol 2008, Feb 23 (in press).
86. A Alavi M Reivich J Greenberg D Christman J Fowler P Hand 1981 Mapping of functional activity in brain with 18-F-fluoro-deoxyglucose Sem Nucl Med 11 24 31
87. A Alavi S Ferris A Wolf D Christman J Fowler R MacGregor 1982 Determination of regional cerebral metabolism in dementia using F-18 deoxyglucose and positron emission tomography Exp Brain Res 5 185 195
88. A Alavi R Dann J Chawluk J Alavi M Kushner M Reivich 1986 Positron emission tomography imaging of regional cerebral glucose metabolism Semin Nucl Med 16 2 34
89. JL Pujol P Demoly JP Daures 1992 Chest tumor response measurement during lung cancer chemotherapy. Comparison between computed tomography and standard roentgenography Am Rev Respir Dis 145 5 1149 1154
90. JF Holmes R Akkinepalli 2005 Computed tomography versus plain radiography to screen for cervical spine injury: a meta-analysis J Trauma 58 5 902 905
91. 99mTc-labeled red cells: single photon emission computed tomography (SPECT) versus planar imaging Liver 9 5 288 293
92. G Ferlin P Zanco R Buchberger B Saitta N Borsato 1988 Stress thallium-201 myocardial scintigraphy: planar imaging versus SPECT J Nucl Med Allied Sci 32 2 82 86
93. A Palla P De Nitto A Santolicandro 1994 Planar versus SPECT studies in lung disease J Nucl Med Biol 38 1 22 36
94. WH Martin D Delbeke JA Patton MP Sandler 1996 Detection of malignancies with SPECT versus PET, with 2-[fluorine-18] fluoro-2-deoxy-d-glucose Radiology 198 1 225 231
95. S Basu H Zaidi M Houseni J Udupa P Acton DA Torigian 2007 Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states Semin Nucl Med 37 3 223 239
96. Basu S, Alavi A. Feasibility of automated partial-volume correction of SUVs in current PET/CT scanners: can manufacturers provide integrated, ready-to-use software? J Nucl Med 2008 (in press).